Scarica l'app Stockscreener
4.32
3.60%
0.15
Pre-mercato:
4.32
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$4.17
Aprire:
$4.19
Volume 24 ore:
657.57K
Relative Volume:
1.08
Capitalizzazione di mercato:
$297.43M
Reddito:
$113.02M
Utile/perdita netta:
$-75.07M
Rapporto P/E:
-4.1431
EPS:
-1.0427
Flusso di cassa netto:
$-47.88M
1 W Prestazione:
+1.89%
1M Prestazione:
+44.00%
6M Prestazione:
+78.51%
1 anno Prestazione:
+50.00%
Intervallo 1D:
$4.01
$4.355
Intervallo di 1 settimana:
$4.00
$4.355
Portata 52W:
$2.08
$4.355
Orasure Technologies Inc Stock (OSUR) Company Profile
Nome
Orasure Technologies Inc
Settore
Industria
Telefono
(503) 641-6115
Indirizzo
220 E FIRST ST, BETHLEHEM, PA
Compare OSUR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
OSUR
Orasure Technologies Inc
|
4.32 | 287.10M | 113.02M | -75.07M | -47.88M | -1.0427 |
ISRG
Intuitive Surgical Inc
|
417.07 | 147.53B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
145.16 | 40.10B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
65.84 | 32.33B | 10.63B | 819.00M | 1.59B | 1.6577 |
MDLN
Medline Inc
|
37.09 | 31.57B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
193.94 | 27.96B | 5.54B | 1.52B | 1.74B | 10.37 |
Orasure Technologies Inc Stock (OSUR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-01-03 | Ripresa | Evercore ISI | In-line |
| 2021-09-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2020-08-21 | Iniziato | Evercore ISI | Outperform |
| 2020-08-10 | Iniziato | Citigroup | Buy |
| 2020-08-10 | Iniziato | JP Morgan | Neutral |
| 2020-08-07 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2020-06-25 | Iniziato | Lake Street | Buy |
| 2020-04-21 | Ripresa | Stephens | Equal-Weight |
| 2018-10-23 | Ripresa | Raymond James | Mkt Perform |
| 2018-07-16 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2017-11-02 | Downgrade | Jefferies | Buy → Hold |
| 2017-02-09 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2016-06-13 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2015-11-05 | Reiterato | Mizuho | Buy |
| 2015-05-07 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| 2015-01-23 | Reiterato | Mizuho | Buy |
| 2014-06-12 | Reiterato | Canaccord Genuity | Buy |
| 2014-06-11 | Reiterato | Mizuho | Buy |
| 2012-12-21 | Iniziato | Mizuho | Buy |
| 2012-08-08 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2012-07-05 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2012-03-27 | Iniziato | JMP Securities | Mkt Outperform |
Mostra tutto
Orasure Technologies Inc Borsa (OSUR) Ultime notizie
OraSure receives FDA clearance for home urine collection kit for STIs - Lehigh Valley Business
Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now? - Yahoo Finance
FDA Clears Home Urine Collection Kit for STI Testing - Conexiant
OraSure Wins FDA Clearance for At-Home STI Collection - TipRanks
OraSure secures FDA clearance for product seen as key to future growth - WFMZ.com
OraSure stock jumps on FDA clearance for at-home STI kit - Investing.com
OraSure stock jumps on FDA clearance for at-home STI kit By Investing.com - Investing.com South Africa
OraSure Technologies (NASDAQ: OSUR) wins FDA clearance for Colli-Pee Dx at-home urine collection kit - Stock Titan
OraSure gets FDA nod for at-home STI urine collection kit By Investing.com - Investing.com Australia
OraSure gets FDA nod for at-home STI urine collection kit - Investing.com India
OraSure receives FDA clearance for at-home STI urine collection kit - StreetInsider
OraSure Technologies, Inc. Announces FDA Clearance that Expands Patient‑Friendly Access to Testing for Sexually Transmitted Infections - The Manila Times
FDA clears at-home urine kit that lets labs test for 4 STIs by mail - Stock Titan
OraSure Technologies (OSUR) Slips 3.1% as Stock Tests Key Support LevelOvernight Profile - newsline.com
Is Cogent Biosciences, Inc. (COGT) A Good Stock To Buy Now? - Yahoo Finance
OraSure Technologies (OSUR) director receives 46,106-share restricted stock grant - Stock Titan
OraSure (OSUR) director Nancy Gagliano receives 46,106-share stock award - Stock Titan
OraSure Technologies (OSUR) director receives 46,106-share stock grant - Stock Titan
OraSure (OSUR) director John P. Kenny granted 46,106 restricted shares - Stock Titan
Director at OraSure (NASDAQ: OSUR) receives 46,106 restricted shares - Stock Titan
Earnings call transcript: OraSure Technologies Q1 2026 misses earnings and revenue forecasts - Investing.com UK
OraSure Technologies Investors Approve Expanded Stock Plan, Governance Changes - The Globe and Mail
OraSure Technologies (NASDAQ: OSUR) OKs more equity awards and board declassification - Stock Titan
OraSure Technologies Hits New 52-Week High of $4.33, Marking Significant Growth - Markets Mojo
OSUR Q1 2026 Earnings: EPS Miss by 69% Signals Operational HeadwindsFree Cash Flow Trends - newsline.com
OraSure Technologies, Inc.Common Stock (NQ: OSUR - FinancialContent
OraSure Technologies (OSUR) Gains 6%: Testing Resistance as Momentum BuildsEase of Movement - The Legal Advocate
OraSure Technologies Hits New 52-Week High at $4.00 - Markets Mojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - Investing.com
OraSure Technologies Hits New 52-Week High at $4.12 - MarketsMojo
Is Co-Diagnostics National Security’s Next Diagnostic Pick? - MarketBeat
OraSure Technologies (OSUR) Gains 3.68% as Stock Approaches Key Resistance LevelNHNL Divergence - The Legal Advocate
OraSure Technologies (OSUR) price target increased by 25.00% to 5.10 - MSN
Insiders Buying OraSure Technologies Might Wish They Invested More, Stock Gains 28% - Moomoo
OraSure Technologies (OSUR) Surges 9%: Key Levels to Watch After Strong MoveBearish Pattern Stocks - The Legal Advocate
OraSure Technologies Inc. (OSUR) Q1 2026 Earnings: Wider-than-Expected Loss Raises Concerns Despite Stock SurgeInvestor Earnings Call - The Legal Advocate
OraSure Technologies (OSUR) Surges 7% as Shares Approach Resistance at $3.45Institutional Volume - newsline.com
Cardiff Oncology And 2 Other Promising Penny Stocks For Your Watchlist - Yahoo Finance
symbol__ Stock Quote Price and Forecast - CNN
OraSure Technologies Independent Director Acquires 195% More Stock - Yahoo Finance
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Insider Buying: Steven Boyd Acquires 75,000 Shares of OraSure Te - GuruFocus
OraSure director Steven Boyd purchases $224,750 in stock By Investing.com - Investing.com India
OraSure director Steven Boyd purchases $224,750 in stock - Investing.com
[Form 3] ORASURE TECHNOLOGIES INC Initial Statement of Beneficial Ownership - Stock Titan
Director at OraSure (NASDAQ: OSUR) awarded 33,661 restricted shares - Stock Titan
Orasure Technologies Inc Azioni (OSUR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Orasure Technologies Inc Azioni (OSUR) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Boyd Steven Kyle | Director |
May 14 '26 |
Buy |
2.99 |
25,000 |
74,750 |
113,462 |
| Boyd Steven Kyle | Director |
May 12 '26 |
Buy |
2.98 |
25,000 |
74,500 |
63,462 |
| McGrath Kenneth J | Chief Financial Officer |
Mar 20 '26 |
Buy |
2.93 |
32,300 |
94,600 |
589,562 |
| EGLINTON MANNER CARRIE | President & CEO |
Mar 20 '26 |
Buy |
2.93 |
32,300 |
94,597 |
2,190,874 |
| McGrath Kenneth J | Chief Financial Officer |
Mar 13 '26 |
Buy |
3.00 |
22,021 |
66,030 |
557,262 |
| EGLINTON MANNER CARRIE | President & CEO |
Mar 13 '26 |
Buy |
3.00 |
22,022 |
66,033 |
2,158,574 |
1.68%
0.71%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):